Print this page
-
A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia.
Protocol: 022404-MM1OA-EA0Principal Investigator:
-
Neil Palmisiano
Applicable Disease Sites: Leukemia, other -
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial).
Protocol: 022404-MM1YA-CTGPrincipal Investigator:
-
Neil Palmisiano
Applicable Disease Sites: Leukemia, other -
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia.
Protocol: 022404-MM1YA-S01Principal Investigator:
-
Neil Palmisiano
Applicable Disease Sites: Leukemia, other -
A Phase II Multicenter Open-label Trial of Tagraxofusp (Tag) in Combination With Venetoclax and Azacitidine (Ven/Aza) in Adults With Previously Untreated CD123+ Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy
Protocol: 022405Principal Investigator:
-
Neil Palmisiano
Applicable Disease Sites: Leukemia, other -
A Phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL).
Protocol: 111707Principal Investigator:
-
Archana Sharma
Applicable Disease Sites: Lymphoid Leukemia -
Characterization of Brain Dysfunction During Development in Survivors of Childhood Acute Lymphoblastic Leukemia.
Protocol: 112002Principal Investigator:
-
Peter D. Cole
Applicable Disease Sites: Leukemia, not otherwise specified -
A Randomized Phase 3 Trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma.
Protocol: 112105Principal Investigator:
-
Archana Sharma
Applicable Disease Sites: Any Site
Lymphoid Leukemia -
Pediatric Acute Leukemia (PedAL) Screening Trial: Developing New Therapies for Relapsed Leukemias.
Protocol: 112204Principal Investigator:
-
Richard A Drachtman
Applicable Disease Sites: Leukemia, not otherwise specified -
A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma.
Protocol: 112305Principal Investigator:
-
Richard A Drachtman
Applicable Disease Sites: Hodgkin's Lymphoma -
A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy.
Protocol: 112308Principal Investigator:
-
Marissa Botwinick
Applicable Disease Sites: Leukemia, other -
A Phase 2 Study of SNDX-5613 in Combination with Chemotherapy for Patients with Relapsed or Refractory KMT2A-Rearranged Infant Leukemia.
Protocol: 112402Principal Investigator:
-
Richard A Drachtman
Applicable Disease Sites: Leukemia, other -
Improving Chemotherapy-Induced Nausea Control Through Bright Ideas®-CIN Training: A Feasibility Study in Children Receiving Oral Chemotherapy.
Protocol: 132104Principal Investigator:
-
Katie Devine
Applicable Disease Sites: Leukemia, not otherwise specified
Leukemia, other -
Exploring Patient and Caregiver Perspectives and Experiences with Financial Toxicity.
Protocol: 132105Principal Investigator:
-
Biren Saraiya
Applicable Disease Sites: Hodgkin's Lymphoma
Leukemia, not otherwise specified
Leukemia, other
Myeloid and Monocytic Leukemia -
Characterizing Lymphoma Survivors Experiences, Needs, and Preferences During the Transition to Cancer Survivorship: The Survivor Health Check Program Development Trial.
Protocol: 132203Principal Investigator:
-
Sharon Manne
Applicable Disease Sites: Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma -
Needs Survey for Childhood, Adolescent, Young Adults (CAYA) Cancer Survivors, Their Siblings, and Parents/Caregivers.
Protocol: 132213Principal Investigator:
-
Katie Devine
Applicable Disease Sites: Any Site
Bones and Joints
Brain and Nervous System
Hodgkin's Lymphoma
Leukemia, not otherwise specified
Leukemia, other
Non-Hodgkin's Lymphoma